Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: Results of CALGB 90202 (Alliance) Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Bone Density Conservation Agents
  • Bone Neoplasms
  • Diphosphonates
  • Imidazoles
  • Prostatic Neoplasms

abstract

  • In men with castration-sensitive prostate cancer and bone metastases, early treatment with zoledronic acid was not associated with lower risk for SREs.

publication date

  • April 10, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3970172

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.51.6500

PubMed ID

  • 24590644

Additional Document Info

start page

  • 1143

end page

  • 50

volume

  • 32

number

  • 11